Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 04, 2022

SELL
$0.9 - $1.31 $55,749 - $81,146
-61,944 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$1.21 - $1.61 $2,300 - $3,060
1,901 Added 3.17%
61,944 $79,000
Q2 2021

Aug 02, 2021

BUY
$1.6 - $2.02 $1,435 - $1,811
897 Added 1.52%
60,043 $98,000
Q1 2021

May 06, 2021

BUY
$1.86 - $2.87 $1,819 - $2,806
978 Added 1.68%
59,146 $117,000
Q4 2020

Jan 28, 2021

SELL
$1.65 - $2.43 $1,613 - $2,376
-978 Reduced 1.65%
58,168 $120,000
Q3 2020

Nov 05, 2020

BUY
$1.6 - $2.35 $23,916 - $35,127
14,948 Added 33.82%
59,146 $101,000
Q2 2020

Aug 04, 2020

BUY
$1.33 - $2.76 $58,783 - $121,986
44,198 New
44,198 $103,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $305M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.